Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1

Patients with neurofibromatosis type 1 (NF1) have an increased lifetime risk for the development of nervous system tumors, including high-grade gliomas (glioblastoma). NF1 is associated with the loss of expression of neurofibromin 1 (NF1 gene product). This hyperactivates the mitogen-activated prote...

全面介紹

Na minha lista:
書目詳細資料
發表在:Case Rep Oncol
Main Authors: Awada, Gil, Serruys, Daphne, Schwarze, Julia Katharina, Van De Voorde, Lien, Duerinck, Johnny, Neyns, Bart
格式: Artigo
語言:Inglês
出版: S. Karger AG 2020
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548872/
https://ncbi.nlm.nih.gov/pubmed/33082744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509773
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍